{
  "config": {
    "clinical_question": "Compare the effectiveness of letrozole+palbociclib with letrozole+ribociclib for the first line treatment of metastatic ER positive breast cancer.",
    "dataset_size": 1000,
    "target_treatment_rate": 0.5,
    "target_treatment_logit_std": 2.0,
    "enforce_positivity": false,
    "min_treatment_rate_per_stratum": 0.1,
    "max_treatment_rate_per_stratum": 0.9,
    "target_control_outcome_mean": 6.0,
    "treatment_effect": 4.0,
    "target_outcome_log_std": 1.0,
    "main_coefficient_scale": 0.3,
    "interaction_coefficient_scale": 0.1,
    "num_confounders": 1,
    "output_dir": "./example_synthetic_data_one_confounder",
    "llm": {
      "api_base_url": "http://localhost:8000/v1",
      "api_key": "",
      "model_name": "openai/gpt-oss-120b",
      "temperature": 0.7,
      "max_tokens": 30000,
      "timeout": 300.0
    },
    "seed": 42
  },
  "confounders": [
    {
      "name": "visceral_disease_status",
      "type": "categorical",
      "categories": [
        "bone_only",
        "lung_only",
        "liver_only",
        "multiple_viscera",
        "no_viscera"
      ],
      "description": "Extent and location of visceral metastases at baseline, which influences both clinician choice of CDK4/6 inhibitor and prognosis"
    }
  ],
  "treatment_equation": {
    "intercept": -1.5283541440652528,
    "coefficients": {
      "visceral_disease_status_lung_only": -1.14520851377465,
      "visceral_disease_status_liver_only": 2.2904170275493,
      "visceral_disease_status_multiple_viscera": 3.43562554132395,
      "visceral_disease_status_no_viscera": -1.908680856291083
    },
    "interactions": [],
    "original_intercept": -0.2
  },
  "outcome_equation": {
    "intercept": -1.0,
    "coefficients": {
      "visceral_disease_status_lung_only": -0.12,
      "visceral_disease_status_liver_only": -0.36,
      "visceral_disease_status_multiple_viscera": -0.44999999999999996,
      "visceral_disease_status_no_viscera": 0.09
    },
    "interactions": [],
    "treatment_coefficient": 4.0,
    "treatment_interactions": [
      {
        "term": "visceral_disease_status_lung_only",
        "coefficient": -0.025091976230527502
      },
      {
        "term": "visceral_disease_status_liver_only",
        "coefficient": 0.09014286128198323
      },
      {
        "term": "visceral_disease_status_multiple_viscera",
        "coefficient": 0.04639878836228102
      },
      {
        "term": "visceral_disease_status_no_viscera",
        "coefficient": 0.01973169683940732
      }
    ]
  },
  "summary_statistics": {
    "age": {
      "type": "continuous",
      "mean": 62.3,
      "std": 9.8
    },
    "ecog_performance_status": {
      "type": "categorical",
      "proportions": {
        "0": 0.22,
        "1": 0.48,
        "2": 0.2,
        "3": 0.1
      }
    },
    "visceral_disease_status": {
      "type": "categorical",
      "proportions": {
        "bone_only": 0.14,
        "lung_only": 0.18,
        "liver_only": 0.26,
        "multiple_viscera": 0.32,
        "no_viscera": 0.1
      }
    },
    "charlson_comorbidity_index": {
      "type": "continuous",
      "mean": 2.1,
      "std": 1.4
    },
    "prior_adjuvant_endocrine_therapy": {
      "type": "categorical",
      "proportions": {
        "none": 0.35,
        "yes": 0.65
      }
    }
  },
  "dataset_statistics": {
    "n_patients": 1000,
    "treatment_rate": 0.507,
    "outcome_mean": 10.93216403531404,
    "outcome_std": 15.198403341224958,
    "mean_treatment_prob": 0.5067493193312437,
    "std_treatment_prob": 0.3514050733299126,
    "mean_y0": 8.90416403531404,
    "std_y0": 15.260744720005064,
    "mean_y1": 12.90416403531404,
    "std_y1": 15.260744720005064,
    "mean_ite": 4.0,
    "std_ite": 5.813522493914215e-16,
    "clinical_text_stats": {
      "non_empty_count": "1000",
      "mean_length": 7973.255
    }
  }
}